Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
03/04/2004 | US20040042970 Inhalable sustained therapeutic formulations |
03/04/2004 | US20040042967 Method of treating a systemic disease |
03/04/2004 | US20040042966 Administering aerosol; pressurized measured dosage |
03/04/2004 | US20040042964 Pharmaceutical composition which reduces or eliminates drug abuse potential |
03/04/2004 | DE4325465B4 Orales pharmazeutisches Präparat für die Schmerztherapie An oral pharmaceutical composition for the treatment of pain |
03/04/2004 | DE20318700U1 Chewing cap for medical and therapeutic purposes has a shape and mechanical properties which allow it to be releasable attached to pencils and/or paint brushes used by young children |
03/04/2004 | DE19758730B4 Electrostatic chuck for manufacturing pharmaceutical products e.g. tablets, inhaler substrate |
03/04/2004 | DE10261126A1 Lagerungsstabile, flüssige Fibrinogen-Formulierung Storage stable liquid fibrinogen formulation |
03/04/2004 | DE10239999A1 Granulat oder Pulver zur Herstellung von Überzugs- und Bindemitteln für Arzneiformen Granules or powders for the preparation of coatings and binders for pharmaceutical forms |
03/04/2004 | DE10237056A1 Transdermal therapeutic systems containing buprenorphine, useful in treating pain or urinary incontinence, also containing mu-, kappa- or delta-opioid receptor antagonist to reduce abuse potential |
03/04/2004 | CA2499280A1 Inhalation compositions with high drug ratios |
03/04/2004 | CA2499278A1 Method of preparing dry powder inhalation compositions |
03/04/2004 | CA2496364A1 Composition for the carrying and delivery of bone growth inducing material and methods for producing and applying the composition |
03/04/2004 | CA2496110A1 Use of an aqueous solution of citric acid and a water-soluble sugar like lactitol as granulation liquid in the manufacture of tablets |
03/04/2004 | CA2496106A1 Fast dissolving and taste masked oral dosage form comprising sildenafil |
03/04/2004 | CA2495923A1 Methods for treating fungal infections |
03/04/2004 | CA2495913A1 Non-vesicular cationic lipid formulations |
03/04/2004 | CA2495689A1 Pharmaceutical compositions |
03/04/2004 | CA2494974A1 Il-7 drug substance, composition, preparation and uses |
03/04/2004 | CA2494658A1 Use of bupropion for the manufacture of a medicament for treating restless legs syndrome |
03/04/2004 | CA2493328A1 Use of a papaverine-like vasodilator and pharmaceutical composition |
03/04/2004 | CA2492807A1 Nanoparticles for dna administration to a target organ |
03/04/2004 | CA2491758A1 Blood clot-targeted nanoparticles |
03/03/2004 | EP1393749A1 A pharmaceutical preparation in colloidal form useful in the treatment of skin diseases, comprising hyluronic acid |
03/03/2004 | EP1393741A1 Storage-stable, liquid fibrinogen-formulation |
03/03/2004 | EP1393736A1 Use of ginkgo biloba terpene free flavonoidic extract for oral hygiene, and composition containing such extract |
03/03/2004 | EP1393732A1 Minoxidil-containing liquid composition |
03/03/2004 | EP1393724A2 Novel formulations for the transdermal administration of fluoxetine |
03/03/2004 | EP1393721A1 Dosage form of powder agglomerates |
03/03/2004 | EP1393720A1 Vesicle-encapsulated corticosteroids for treatment of cancer |
03/03/2004 | EP1393719A1 Camptothecin-carboxylate formulations |
03/03/2004 | EP1393718A1 Colloidal drug carrier system |
03/03/2004 | EP1393716A2 Cool feeling composition |
03/03/2004 | EP1392846A2 METHODS AND COMPOSITIONS FOR MODIFYING APOLIPOPROTEIN B mRNA EDITING |
03/03/2004 | EP1392840A2 Method for producing proteins by fermentation of microorganisms from the thermus family, the protein mixture thus obtained and cosmetic compositions containing same |
03/03/2004 | EP1392785A1 System for releasing active substances and active agents |
03/03/2004 | EP1392756A2 Lipid-polymer-conjugates |
03/03/2004 | EP1392755A1 Lipid-polymer-conjugates compositions |
03/03/2004 | EP1392389A2 Microprojection array having a beneficial agent containing coating |
03/03/2004 | EP1392381A1 An aerosol forming device for use in inhalation therapy |
03/03/2004 | EP1392375A2 Composition and use of substances for stabilising amino acids containing sulphur |
03/03/2004 | EP1392365A2 Compositions and therapeutical use of polynucleotides encoding tcrs |
03/03/2004 | EP1392364A2 Liquid polymer composition for prevention and treatment of the oral cavity diseases |
03/03/2004 | EP1392352A1 Use of an antioxidant for treating and/or preventing surface ocular disorders |
03/03/2004 | EP1392350A2 Optimization of the molecular properties and formulation of proteins delivered by inhalation |
03/03/2004 | EP1392337A1 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating |
03/03/2004 | EP1392334A2 Therapeutic methods using herbal compositions |
03/03/2004 | EP1392327A2 Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases |
03/03/2004 | EP1392325A1 Method of administration of bisphosphonates by inhalation in the treatment or prevention of bone resorption and osteoporosis |
03/03/2004 | EP1392321A1 Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids |
03/03/2004 | EP1392277A2 Pharmaceutical compositions comprising a hmg-coa reductase inhibitor |
03/03/2004 | EP1392274A1 Improved dosage form of n-acetyl cysteine |
03/03/2004 | EP1392272A1 Permeation enhancers |
03/03/2004 | EP1392271A1 Swallow tablet comprising paracetamol |
03/03/2004 | EP1392270A2 Abuse resistant pharmaceutical composition containing capsaicin |
03/03/2004 | EP1392265A2 Inhibitors of abc drug transporters at the blood-brain barrier |
03/03/2004 | EP1392264A1 Delivery of antiemetics through an inhalation route |
03/03/2004 | EP1392263A2 Delivery of aerosols containing small particles through an inhalation route |
03/03/2004 | EP1392262A1 Delivery of drug esters through an inhalation route |
03/03/2004 | EP1392261A2 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route |
03/03/2004 | EP1392260A2 Delivery of benzodiazepines through an inhalation route |
03/03/2004 | EP1392259A2 Delivery of erectile dysfunction drugs through an inhalation route |
03/03/2004 | EP1392258A2 Delivery of alprazolam, estazolam, midazolam or triazolam throughan inhalation route |
03/03/2004 | EP1392257A1 Delivery of antihistamines through an inhalation route |
03/03/2004 | EP1392256A1 Improved transdermal therapeutic system for the treatment of parkinson's disese |
03/03/2004 | EP1392255A1 Nanoparticles made of protein with coupled apolipoprotein e for penetration of the blood-brain barrier and methods for the production thereof |
03/03/2004 | EP1392254A1 Micellar drug delivery systems for hydrophobic drugs |
03/03/2004 | EP1392253A2 Gelatin substitute |
03/03/2004 | EP1392252A2 Pharmaceutical composition containing stool softener such as polaxamer and enteric coated particles of bisacodyl |
03/03/2004 | EP1392251A1 Method of tablet enrobing |
03/03/2004 | EP1392250A2 Controlled release dosage forms using acrylic polymer, and process for making the same |
03/03/2004 | EP1392249A1 Nsaid formulation comprising a granular composition and an extra-granular composition |
03/03/2004 | EP1392248A1 Homogenised product for implants and microparticles |
03/03/2004 | EP1392247A2 Process for preparing granular compositions |
03/03/2004 | EP1392246A1 Compaction process for manufacture of sodium phenytoin dosage form |
03/03/2004 | EP1392245A2 Process for making protein delivery matrix and uses thereof |
03/03/2004 | EP1392244A2 Pharmaceutical compositions |
03/03/2004 | EP1392243A2 Topical composition with a lamellar double-membrane structure, containing a n-acyl-ethanolamine and/or a quaternary ammonium salt and/or an adenosylmethionine |
03/03/2004 | EP1392242A1 Method of forming an aerosol for inhalation delivery |
03/03/2004 | EP1392241A2 System for osmotic delivery of pharmaceutically active agents |
03/03/2004 | EP1392240A1 Formulation comprising melt granules of nsaids and organic acids |
03/03/2004 | EP1392133A2 Functional agent for decomposing nicotine and method of preparing the same |
03/03/2004 | EP1392116A1 Solutions of alkoxylated alkanol amide surfactants and antimicrobial compounds |
03/03/2004 | EP1392115A1 Controlled release particles |
03/03/2004 | EP1259128A4 Water containing soluble fiber |
03/03/2004 | EP1185253B1 Oral administration form for administering a fixed tramadol and diclofenac combination |
03/03/2004 | EP1175257B1 Spray drying apparatus and methods of use |
03/03/2004 | EP1162953B1 Mechanically stable pharmaceutical presentation form containing liquid or semi-solid surface-active substances |
03/03/2004 | EP1159049B1 Responsive gels and methods of use thereof |
03/03/2004 | EP1140020B1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles |
03/03/2004 | EP1140012B1 Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings |
03/03/2004 | EP1135092B1 Cleavable solid dosage forms and method for the production thereof |
03/03/2004 | EP1125575B1 Perfusate preparation for ophthalmic operation |
03/03/2004 | EP1113787B1 Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same |
03/03/2004 | EP1100540B1 Process for the preparation of granular and porous sucralfate dry gel |
03/03/2004 | EP1073426B1 Pharmaceutical cyclosporin formulation with improved biopharmaceutical properties, improved physical quality and greater stability, and method for producing said formulation |
03/03/2004 | EP1041968B1 Osmotic delivery system with membrane plug retention mechanism |
03/03/2004 | EP1037615B1 Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate |
03/03/2004 | EP1019025B1 Peptide/lipid complex formation by co-lyophilization |
03/03/2004 | EP1015017B1 Implantable system with drug-eluting cells for on-demand local drug delivery |